DKK3 and cancer: Our results are in line with previous studies of DKK3 down-regulation and methylation in a variety of cancer cell lines and tissues [24, 38–44], and its transcriptional silencing is at least partly because of aberrant hypermethylation of the promoter [16, 17, 20, 21, 25, 45–48].